Granisetron Hydrochloride
Who holds supplier records for Granisetron Hydrochloride? 15 organisations hold a current record for Granisetron Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (4), Taiwan (2), Israel (2) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Granisetron Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/granisetron-hydrochloride
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Granisetron Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Natco PharmaIndia Company GMP cert on recordActive DMF 19215, 20678 · latest filing Jul 2007
- SWATI SPENTOSE PRIVATE LTDIndiaActive DMF 44703, 35147 · latest filing Sept 2026
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChinaCEPActive DMF 16838 · latest filing Sept 2003
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17793 · latest filing Oct 2004
- HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDChinaCEPActive DMF 19078 · latest filing Dec 2005
- Hubei Haosun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 19365 · latest filing Apr 2006
- INKE SASpainCEPActive DMF 17346 · latest filing Apr 2004
- ORBION PHARMACEUTICALS PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19967 · latest filing Nov 2006
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 20869 · latest filing Sept 2007
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 13844 · latest filing Nov 1998
- HIKMA PHARMACEUTICALSActive DMF 25298 · latest filing Sept 2011
- SYN-TECH CHEM AND PHARM CO LTDTaiwanActive DMF 26504 · latest filing Sept 2012
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 19947 · latest filing Nov 2006
- Wockhardt LimitedIndia Company GMP cert on recordActive DMF 19708 · latest filing Aug 2006
- ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Granisetron Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CIPLA LIMITED Mumbai | IN | CEP 2007-051 - Rev 03 Granisetron hydrochloride | Apr 2026 | — |
| ORBION PHARMACEUTICALS PRIVATE LIMITED Irungattukottai | IN | CEP 2020-006 - Rev 02 Granisetron hydrochloride, Site II | Aug 2025 | Inspected Aug 2024 Germany |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2007-217 - Rev 05 Granisetron hydrochloride | Oct 2024 | — |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2007-341 - Rev 02 Granisetron hydrochloride | Sept 2024 | — |
| HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City | CN | CEP 2008-184 - Rev 02 Granisetron hydrochloride | Feb 2024 | — |
| QILU PHARMACEUTICAL CO., LTD. Jinan | CN | CEP 2011-295 - Rev 03 Granisetron hydrochloride | Sept 2023 | Inspected Feb 2025 Switzerland |
| Chongqing Carelife Pharmaceutical Co. Ltd. Chongqing | CN | R1-CEP 2007-247 - Rev 02 Granisetron hydrochloride | Mar 2021 | — |
| HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou | CN | R1-CEP 2009-341 - Rev 03 Granisetron hydrochloride | Apr 2018 | — |
| INKE, S.A. Castellbisbal | ES | R1-CEP 2008-030 - Rev 01 Granisetron hydrochloride | Mar 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Granisetron Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- HAMARI CHEMICALS LTDInactive DMF 23588 · filed Feb 2010
- MYLAN LABORATORIES LTDInactive DMF 19070 · filed Dec 2005
- India · Inactive DMF 18426 · filed Jun 2005
- Amino Chemicals LtdMalta · Inactive DMF 17476 · filed Jun 2004
- China · Inactive DMF 16560 · filed Apr 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Granisetron Hydrochloride is a serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to treat nausea and vomiting following chemotherapy. It works by blocking serotonin from binding to 5-HT3 receptors located on vagal nerve terminals and in the chemoreceptor trigger zone.
Chemical identity
- IUPAC name
- 1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride
- Canonical SMILES
- CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl
- InChIKey
- QYZRTBKYBJRGJB-PCMHIUKPSA-N
- Synonyms
- Kytril API, bema granisetron, brl 43694a, granisetron (as hydrochloride), granisetron hcl, kytril, nsc-759839
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin-3 Receptor Antagonist
- Mechanism of action
- Serotonin 3 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Granisetron Hydrochloride?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Granisetron Hydrochloride: Natco Pharma (India), SWATI SPENTOSE PRIVATE LTD (India), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Cipla Limited (India), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China), Hubei Haosun Pharmaceutical Co., Ltd. (China), INKE SA (Spain) and ORBION PHARMACEUTICALS PRIVATE LTD (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Granisetron Hydrochloride Drug Master Files are active?
Natco Pharma (DMF 19215, 20678), SWATI SPENTOSE PRIVATE LTD (DMF 44703, 35147), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 16838), Cipla Limited (DMF 17793), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (DMF 19078), Hubei Haosun Pharmaceutical Co., Ltd. (DMF 19365), INKE SA (DMF 17346) and ORBION PHARMACEUTICALS PRIVATE LTD (DMF 19967) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Granisetron Hydrochloride records mean?
5 organisations have only inactive Type II DMFs for Granisetron Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Granisetron Hydrochloride have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Granisetron Hydrochloride on the EDQM register, including CIPLA LIMITED Mumbai (IN), ORBION PHARMACEUTICALS PRIVATE LIMITED Irungattukottai (IN), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL), SCINOPHARM TAIWAN LTD. Shan-Hua (TW), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City (CN) and QILU PHARMACEUTICAL CO., LTD. Jinan (CN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Granisetron Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Granisetron Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.